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Abstract 
The relationship between L-cystine transport and intracellular glutathione (GSH) levels was investigated in cultured 
pancreatic AR42J acinar and 13TC3 islet cells exposed to diethylmaleate, anelectrophilic agent known to activate cellular 
antioxidant responses. Cystine transport was mediated predominantly b the Na÷-independent a ionic amino acid transport 
system x~, with influx inhibited potently by glutamate and homocysteate but unaffected by cationic or neutral amino acids. 
Saturable cystine transport was 10-fold higher in AR42J (531 pmol (mg protein) -1 min -l) than in I~TC3 (49 pmol (mg 
protein)-1 min-l) cells, and GSH levels were higher in AR42J cells. Treatment with 2-mercaptoethanol i creased GSH levels 
in [3TC3 cells from 7.5 to 36 nmol (mg protein) -1 , whilst the GSH content in AR42J cells (64 nmol (mg protein) -1) was not 
altered significantly. Incubation of AR42J or ~ITC3 cells with homocysteate (2.5 mM, 0-48 h), a competitive inhibitor of 
cystine transport via system x~-, reduced intracellular GSH levels and resulted in a time-dependent (6-24 h) induction of 
system x~- transport activity. Treatment of AR42J cells with diethylmaleate (100 ktM, 0-48 h) resulted in a time- (5-10 h) and 
protein synthesis-dependent induction of cystine transport, with intracellular GSH levels initially decreasing and then 
increasing 2-fold above control levels after 24 h. Diethylmaleate also depressed GSH levels in [~TC3 cells, but cystine 
transport was not elevated significantly. In both AR42J and 13TC3 cells, inhibition of y-glutamyl cysteine synthetase by 
buthionine sulphoximine (100 ~tM, 24 h) reduced GSH levels but had no effect on cystine transport. The present findings 
establish that induction of system x~- leads to changes in GSH levels in pancreatic AR42J acinar and [~TC3 islet cells, with 
changes in the intracellular redox state stimulating transporter xpression. Induction of activity of system x~-, together with 
adaptive increases in GSH synthesis in response to oxidative stress, may contribute to cellular antioxidant defences in 
pancreatic disease. © 1998 Elsevier Science B.V. All rights reserved. 
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1. Introduction 
Acute inflammatory pancreatitis is characterized 
* Corresponding author. Fax: +44 (171) 3334008; 
E-mail: giovanni.mann@kcl.ac.uk 
by severe acinar cell damage, extensive interstitial 
oedema, haemorrhage and migration of neutrophils 
into the damaged pancreatic gland [1]. Accumulating 
evidence suggests that reactive oxygen metabolites 
play an important step in the initiation and progres- 
sion of acute pancreatitis [2-7]. Although pancreatic 
levels of glutathione are rapidly depleted in experi- 
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mental models of acute pancreatitis [7], there is only 
limited information on the mechanisms regulating 
glutathione synthesis and turnover in pancreatic aci- 
nar and islet cells [8]. 
As the key intracellular antioxidant, glutathione 
(GSH) reacts with electrophilic compounds and 
serves as a reductant for eliminating hydrogen per- 
oxide and lipid hydroperoxides [9]. Supply of cys- 
t(e)ine is rate-limiting for GSH biosynthesis in 
many cell types and, as cysteine is rapidly oxidized 
to cystine in extracellular fluid, cystine predominates 
in plasma and culture media. Transport of cystine is 
usually mediated by a Na+-independent a ionic ami- 
no acid transport system x~, which exchanges cystine 
for intracellular glutamate [9-12]. Within cells cystine 
is rapidly reduced to cysteine, which is used for GSH 
and protein synthesis or released from the cell via the 
Na+-dependent and Na+-independent neutral amino 
acid transport systems ASC and asc, respectively. 
We have previously reported that the electrophilic 
agent diethylmaleate induced adaptive increases in 
cystine transport and intracellular GSH levels in 
the human pancreatic duct cell line PaTu8902 [13]. 
In the present study we have characterized cystine 
transport in rat acinar AR42J [14] and murine islet 
[3TC3 [15] cell lines and investigated whether induc- 
tion of cystine transport activity in response to sub- 
strate deprivation or diethylmaleate r gulates intra- 
cellular GSH levels. A preliminary account of this 
work has been presented in abstract form [16]. 
2. Methods 
2.1. Culture of pancreatic AR42J acinar and flTC3 
islet cell lines 
The rat pancreatic acinar cell line AR42J [14] was 
purchased from the American Type Culture Collec- 
tion (Rockville, MD, USA) and the murine islet cell 
line ~TC3 [15] was a kind gift from Dr. Elaine Bai- 
leys from Addenbrooks Hospital (University of 
Cambridge, UK). Both pancreatic cell lines were cul- 
tured in Dulbecco's modified Eagle medium 
(DMEM) containing 5.6 mM D-glucose, 10% fetal 
calf serum, 2 mM glutamine, 50 U ml-I penicillin, 
and 50 mg m1-1 streptomycin at 37°C in a 5% CO2 
atmosphere [17]. Cells were subcultured every 2-3 
days with a seeding ratio of 1:5-1:10 for AR42J cells 
or every 4-5 days with a seeding ratio of 1:2-1:3 for 
~TC3 cells. AR42J and [~TC3 cells were trypsinized, 
and 2× 105 and 2× 106 cells were plated into 35 mm 
diameter plastic culture dishes, respectively. Two 
days later confluent cell monolayers were exposed 
for up to 48 h to different extracellular amino acids 
(2.5 raM), including L-serine, L-leucine, L-arginine, 
L-aspartate, L-glutamate or L-homocysteate, or the 
electrophilic agent diethylmaleate (DEM, 100 ~M). 
Initial rates of L-cystine transport (2 min) and total 
intraceUular glutathione levels were then measured 
after specified time intervals. 
2.2. Measurement of L-cystine transport 
Initial rates of L-cystine transport were determined 
as described previously [10]. Cells in 35 mm culture 
dishes were rinsed three times with warmed phos- 
phate buffered saline (PBS) (mmol/1): Na2PO4, 80, 
NaHPO4, 20, NaCl, 137, KC1, 3, CaCl2, 1, MgC12, 
0.5, glucose, 5.6, pH 7.4). Cells were then incubat- 
ed at 37°C in 0.5 ml of fresh PBS, containing 
L-[14C]cystine (0.1 ktCil0.5 ml). Transport of L-cystine 
was linear for up to 5 rain (data not shown), and 
hence all subsequent experiments were performed 
over a 2 min incubation interval to maximize radio- 
activity in cell extracts and unidirectional flux meas- 
urements. In experiments where L-cystine transport 
was determined under nominally sodium-free condi- 
tions, sodium containing compounds in the buffer 
were replaced by their choline equivalents. Kinetics 
of L-cystine transport in AR42J and ~TC3 cells were 
examined at L-cystine concentrations ranging from 
0.01 to 0.5 raM. Data for AR42J cells were best 
fitted by a single Michaelis-Menten hyperbola, with 
mean influx values weighted for their reciprocal 
standard error. Kinetics of L-cystine transport in 
~TC3 cells were best fitted by a Michaelis-Menten 
equation with a linear non-saturable component. 
Data were analysed using FigP 60 software (Biosoft). 
Transport was terminated by rapid removal of 
transport buffer from the cells followed by three 
washes with ice-cold PBS. After addition of 0.5 M 
NaOH to each well, total cellular protein concentra- 
tions were determined using the BCA protein assay. 
Disintegrations per minute (dpm) in each sample 
were determined by liquid scintillation and rates of 
amino acid transport were expressed as pmol (mg 
protein) -t min -1 [18]. 
A 
2.3. Determination of  intracellular glutathione levels 
AR42J and ~TC3 cell monolayers in 35 mm dishes 
were rinsed three times with ice-cold PBS, and to- 
tal glutathione (comprised of reduced (GSH) and 
oxidized (GSSG) glutathione) was extracted with 
1 ml of 5% trichloroacetic a id. To remove trichloro- 
acetic acid, cell extracts were treated four times with 
2 ml of 0.01 M HCl-saturated iethyl ether. The 
glutathione content (defined as total GSH) in the 
solution was measured using an enzymatic method 
described previously [12], which is based on the 
catalytic action of glutathione in the reduction of 
5,5'-dithiobis(2-nitrobenzoic ac d) by glutathione re- 
ductase [19]. 
2.4. Materials 
DMEM, fetal calf serum, glutathione reductase 
(type III), buthionine sulphoximine, diethylmaleate, 
2-mercaptoethanol and all other chemicals were pur- 
chased from Sigma (Poole, UK). The BCA protein 
assay kit was obtained from Pierce (Chester, UK) 
and L-[U-14C]cystine (291.3 mCi mmo1-1) from 
New England Nuclear (Dreieich, Germany). 
2.5. Statistics 
Data are expressed as mean+ S.D. of measure- 
ments in n experiments conducted on different 
days. Statistical significance was assessed using a Stu- 
dent's unpaired t-test, with P< 0.05 considered sig- 
nificant. 
3. Results 
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Fig. 1. Kinetics and specificity of L-cystine transport in the rat 
pancreatic acinar cell line AR42J. (A) Cystine transport was 
measured over 2 min in confluent monolayers incubated with 
the specified substrate concentrations (0.01-0.5 mM). Influx 
data were fitted by a single Michaelis-Menten try site analysis 
weighted for the reciprocal standard deviation of each mean in- 
flux value (see Section 2). (B) Initial rates of L-cystine transport 
(0.05 mM, 2 min) were measured in cells incubated in Na ÷ con- 
taining transport buffer in the absence (Ctl) or presence of a 
specified putative inhibitor amino acid (2.5 mM). HC, e-homo- 
cysteate; Glu, L-glutamic acid; Asp, e-aspartic acid; Arg, e-ar- 
ginine; Ser, L-serine; Leu, e-leucine. Values denote the 
means +S.D. of four to six experiments. *P < 0.05 relative to 
control. 
3.1. Characteristics of  cystine transport in AR42J  
cells and flTC3 cells 
Fig. 1A shows the kinetics of cystine transport in 
cultured pancreatic AR42J acinar cells. Influx of cys- 
tine was saturable, with Km and Vmax values similar 
to those reported for system x c in other cell types 
(see Table 1) [9]. To characterize the specificity of 
cystine transport, influx was measured in the pres- 
ence of a 50-fold excess concentration of putative 
inhibitor amino acids. As shown in Fig. 1B, trans- 
port of cystine in AR42J cells was inhibited signifi- 
cantly by L-glutamate and L-homocysteate (sub- 
strates for system Xc). The lack of inhibition of 
L-cystine transport by L-arginine, L-serine, L-leucine 
88 H. Sato et aL /Biochimica et Biophysica Acta 1414 (1998) 85-94 
A 
I C 
J 
8s  
o 
I _ 
o.  
w 
B 
180 
150 
120 
90 
60 
30 
o 
o.o 
A 
I C 
'E "[= 
R 
¢o . _  
®o 
. _  Q .  
E 
0.  
50 
40 
30 
20 
10 
BTC3 
400 
I C 
~, .[= 300 
p 200 
,~ o. 
{ - -  
"J ~ 100 
i i I i i 0 
0.1 0.2 0.3 0.4 0.5 
L-Cystine {raM} 
B 
0 
CII HC Glu Asp Arg Ser Leu 
Fig. 2. Kinetics and specificity of L-cystine transport in the 
murine pancreatic islet cell line ~TC3. (A) Cystine transport 
was measured over 2 min (0.01-0.5 mM), and influx values 
weighted for the reciprocal standard deviation were fitted by a 
Michaelis-Menten equation including a non-saturable compo- 
nent. Overall (o) and saturable (©) rates of cystine transport 
are shown. (B) Initial rates of L-cystine transport (0.05 mM, 
2 min) were measured in cells incubated in PBS in the absence 
(Ctl) or presence of a specified putative inhibitor amino acid 
(2.5 mM). HC, L-homocysteate; Glu, L-glutamic acid; Asp, 
L-aspartic acid; Arg, L-arginine; Ser, L-serine; Leu, L-leucine. 
Values denote the means + S.D. of four to six different experi- 
ments. *P < 0.05 relative to control. 
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Fig. 3. Time course of L-homocysteate-induced hanges in cys- 
tine transport and intracellular GSH levels in AR42J cells. Cell 
monolayers were cultured for 0-48 h in the absence (©) or pres- 
ence of 2.5 mM L-homocysteate (o). Initial rates of L-cystine 
transport (A, 0.05 mM, 2 min) and total intracellular GSH lev- 
els (B) were then measured at the specified time intervals. Val- 
ues denote the means_+ S.D. of four experiments. *P < 0.05 rel- 
ative to control rates of cystine transport at time zero. GSH 
levels after treatment with homocysteate were all significantly 
decreased relative to control GSH levels. 
Table 1 
Summary of kinetic parameters for cystine transport in pancreatic AR42J acinar and I3TC3 islet cell lines 
Km (~M) Vmax (pmo1 (mg protein) -1 min - j )  Kd (pmol (mg protein) -1 min -1) 
AR42J cells 98 + 10 531 + 16 
I]TC3 cells 45 + 10 49 -+ 4 193 + 6 
Pancreatic ells were cultured for 24 h and then the kinetics of cystine transport were measured over a 50-fold range of substrate con- 
centrations (0.01-0.5 mM). Kinetic parameters were weighted for the reciprocal error at each mean and fitted by Michaelis-Menten 
equations as described in Section 2. Values denote the mean + S.D. of four experiments. 
A 
and L-aspartate demonstrates that cystine enters 
these cells via system x~- and not by systems y+, L, 
ASC, b °,+, B °,+, or XAG (see review [20]). 
In pancreatic ~TC3 islet cells, transport of cystine 
was comprised of saturable and non-saturable com- 
ponents (Fig. 2A), with the l/max value for saturable 
transport 10-fold lower than that measured in AR42J 
acinar cells (Table 1). Although an apparent non- 
saturable component exists, further characterization 
of this component could not be performed due to the 
low solubility of cystine. As in AR42J acinar cells, 
the total transport of cystine in I3TC3 cells was only 
inhibited by L-glutamate and L-homocysteate (Fig. 
2B). Cystine transport in both AR42J and ~TC3 cells 
was Na+-independent (data not shown), and the se- 
lective inhibition of cystine transport by glutamate 
and homocysteate together with the Na + independ- 
ence of influx are consistent with transport being 
mediated by system xc-. 
3.2. Modulation of GSH levels and cystine transport 
in AR42J and flTC3 cells 
Table 2 compares total intracellular GSH levels in 
AR42J acinar and [3TC3 islet cells cultured for 24 h 
in the absence or presence of elevated concentrations 
of different amino acids. Pretreatment of AR42J and 
[3TC3 cells with 2.5 mM L-glutamate or L-homocys- 
teate significantly decreased intracellular GSH levels, 
Table 2 
Effects of extracellular amino acids on intracellular GSH levels 
in AR42J acinar and I]TC3 islet cells 
Extracellular amino acid Total intracellular GSH 
(nmol (mg protein) - ] )  
AR42J cells ~TC3 cells 
Control 71 _+ 8 8.0 _+ 0.8 
L-Homocysteate 22 _+ 10" 1.2 _ 0.4* 
L-Glutamate 31 _+ 11 * 2.3 _+ 0.6" 
L-Aspartate 64 _+ 7 6.3 _+ 0.6 
L-Arginine 76 _+ 9 8.3 _+ 0.6 
L-Serine 61 _+ 4 6.9 _+ 0.3 
L-Leucine 65 _+ 3 7.3 _+ 0.6 
Cells were incubated for 24 h in complete DMEM containing a 
given amino acid (2.5 raM). Total intracellular glutathione lev- 
els were then determined in washed cell extracts as described in 
Section 2. Values denote the means_+ S.D. of four experiments. 
*P < 0.05 relative to control GSH content in AR42J and ~TC3 
cells, respectively. 
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whereas L-aspartate, L-arginine, L-serine or L-leucine 
had no such effect. The selective inhibition of cystine 
transport caused by glutamate and homocysteate (see 
Fig. 1B and Fig. 2B) most likely explains the sus- 
tained decrease in GSH levels observed in both pan- 
creatic cell lines. 
In subsequent experiments, we examined the time 
course (0-48 h) of homocysteate-induced changes in 
cystine transport and total intracellular GSH levels. 
Fig. 4. Time course of L-homocysteate-induced changes in cys- 
tine transport and intracellular GSH levels in 13TC3 cells. Cell 
monolayers were cultured for 0-48 h in the absence (©) or pres- 
ence of 2.5 mM L-homocysteate (o). Initial rates of L-cystine 
transport (A, 0.05 mM, 2 min) and total intracellular GSH lev- 
els (B) were then measured at the specified time intervals. Val- 
ues denote the means_+ S.D. of seven to nine experiments. 
*P<0.05  relative to control cystine transport rates at time 
zero. GSH levels after treatment of cells with homocysteate 
were all significantly decreased relative to control GSH levels. 
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Fig. 5. Time-dependent effects of diethylmaleate on cystine 
transport and intracellular GSH levels in AR42J cells. Conflu- 
ent cell monolayers were cultured for 0~8 h in the absence (©) 
or presence (e) of 100 IxM diethylmaleate. Monolayers were 
then rinsed and initial rates of L-cystine transport (A, 0.05 mM, 
2 min) and total intracellular GSH levels (B) measured at the 
specified time intervals. Values denote the means + S.D. of seven 
to nine experiments. *P < 0.05 relative to control values at time 
zero. 
In the absence of homocysteate, initial rates of cys- 
tine transport and GSH levels in AR42J (Fig. 3) and 
[~TC3 (Fig. 4) cells remained constant over a 48 h 
incubation period. Exposure of both cell types to 2.5 
mM homocysteate resulted in a time-dependent in- 
crease in cystine transport, which was detectable 
within 5 h and reached a maximum after 25 h treat- 
ment. Although cystine transport rates were elevated 
after 5 h exposure to homocysteate, intracellular 
GSH levels decreased significantly and remained de- 
pressed below control levels throughout the 48 h in- 
cubation period (Fig. 3BFig. 4B). 
3.3. Effects of  diethylmaleate on cystine transport and 
GSH content 
Cystine transport and intracellular GSH levels 
were also examined in AR42J (Fig. 5A) and I3TC3 
(Fig. 6A) cells treated with diethylmaleate, a sulf- 
hydryl reactive agent proposed to activate electro- 
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Fig. 6. Time-dependent effects of diethylmaleate on cystine 
transport and intracellular GSH levels in 15TC3 cells. Confluent 
cell monolayers were cultured for 048  h in the absence ((3) or 
presence (o) of 100 ~tM diethylmaleate, and initial rates of 
L-cystine transport (A, 0.05 mM, 2 min) and total intracellular 
GSH levels (B) measured at the specified time intervals. Values 
denote the means +_ S.D. of seven to nine experiments. *P < 0.05 
relative to control values at time zero. 
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phile-responsive/antioxidant-responsive elements in 
genes encoding the transporter for system x c and 
the haem degrading enzyme haem oxygenase-1 
[21,22]. In the absence of diethylmaleate, initial rates 
of cystine transport in both pancreatic ell lines re- 
mained constant over a 48 h incubation period. 
Treatment of AR42J cells with diethylmaleate (100 
~tM) increased cystine transport activity from 150 to 
500 pmol (mg protein) -1 min -1 within 1~20 h, and 
thereafter transport rates decreased to control values 
within 48 h. Transport of L-cystine in [~TC3 cells 
exposed to diethylmaleate was not significantly ele- 
vated, with rates of cystine transport only increasing 
from 50 to 65 pmol (mg protein) -1 min -1 after 25 h. 
Diethylmaleate-induced increases in cystine transport 
activity in AR42J cells lines were abolished following 
inhibition of protein synthesis with cycloheximide 
(CLX, 1 ~tM); control: 120+20; DEM: 550+ 140; 
DEM+CLX: 110+20 pmol (mg protein) -1 min 1 
(n = 4-6). Actinomycin D (0.1 Ixg ml-l) also inhibited 
the induction of cystine transport activity by dieth- 
ylmaleate (data not shown). Thus, the significant in- 
crease in cystine transport activity in AR42J cells in 
response to diethylmaleate suggests that this sulf- 
hydryl reagent induced a time-dependent synthesis 
of x~- transporter protein. 
Diethylmaleate (100 ~tM) reduced total intracellu- 
lar GSH levels in AR42J cells from 60 to 23 nmol mg 
protein -1 within 6 h (Fig. 5B). GSH levels were re- 
stored by 12 h, subsequently increased to 125 nmol 
(mg protein)-1 and remained elevated for up to 48 h. 
GSH levels were also decreased in I3TC3 cells after 
6 h exposure to diethylmaleate (Fig. 6B), although 
the subsequent recovery of GSH levels was delayed 
compared to AR42J cells. 
3.4. Effects of  buthionine sulphoximine and 
2-mercaptoethanol on GSH levels and cystine 
transport 
To investigate whether inhibition of GSH synthesis 
influenced cystine transport, AR42J acinar and I3TC3 
islet cells were exposed for 24 h to buthionine sul- 
phoximine (100 gM), an inhibitor of ~/-glutamyl-cys- 
teine synthetase. Buthionine sulphoximine decreased 
intracellular GSH levels significantly in both pancre- 
atic cell lines without altering initial rates of cystine 
transport (Table 3), suggesting that inhibition of 
GSH synthesis alone does not induce system x c 
transport activity. It is worth noting that basal 
GSH levels in [~TC3 cells were significantly lower 
than in AR42J cells. As extracellular thiol supple- 
mentation increases intracellular GSH levels in cells 
deficient in cystine transport activity [8,23], we exam- 
ined the effects of 2-mercaptoethanol n cystine 
transport and GSH levels. Treatment with 2-mercap- 
toethanol (50 gM) for 24 h significantly elevated in- 
tracellular GSH levels in [3TC3 cells, whilst changes 
were less marked in AR42J cells expressing an 8-fold 
higher basal content of GSH (Table 3). 
4. Discussion 
The present study provides the first data on the 
specificity and kinetics of cystine transport in pancre- 
atic AR42J acinar and [3TC3 islet cell lines. The Na + 
independence and marked inhibition of cystine trans- 
port by homocysteate and glutamate suggests that 
both pancreatic ell types express the Na+-independ - 
ent anionic amino acid transport system x c. Pro- 
Table 3 
Effect of buthionine sulphoximine and 2-mercaptoethanol on cystine transport and total intracellular GSH levels in AR42J acinar and 
[3TC3 islet cells 
AR42J cells ~TC3 cells 
Cystine transport Total GSH 
(pmol (rag protein) -1 min -t) (nmol (mg protein) -I) 
Cystine transport Total GSH 
(pmol (rag protein)-l min- l) (nmol (mg protein) 1) 
Control 148 + 33 64 + 12 47 + 17 7.5 ± 1.2 
2-Mercaptoethanol 149 + 21 90 + 16 30 + 5 36 + 7* 
BSO 160+_ 19 8 + 3* 62 + 20 1.2+ 1.1" 
Cells were cultured for 24 h in the absence (control) or presence of 100 ~tM buthionine sulphoximine (BSO) or 50 I.tM 2-mercaptoe- 
thanol, and cystine transport (50 ~tM) and total intracellular GSH levels were then measured. Values denote the means +S.D. of three 
to four experiments. *P < 0.05 relative to the respective control values. 
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longed inhibition of cystine influx by homocysteate 
resulted in a sustained ecrease in total intracellular 
GSH levels and a time- and protein synthesis-de- 
pendent induction of system x~- transport. The sulf- 
hydryl reactive agent diethylmaleate, known to acti- 
vate electrophile-responsive elements in stress 
response genes [24], may have induced the x~- trans- 
porter protein itself and/or a putative activator of 
system x~-. Induced x c transport activity was accom- 
panied by an adaptive increase in intracellular GSH 
levels. The importance of system x~- in maintaining 
GSH levels in these pancreatic acinar and islet cell 
lines confirms previous findings in other cell types 
[11,12,25,26], and provides the first such evidence in 
exocrine and endocrine cells involved in inflamma- 
tory responses in pancreatic diseases [7]. 
We have reported previously that human pancre- 
atic PaTu8902 duct cells transport cystine via system 
x c and a y-glutamyl-dipeptide transporter [18], which 
transports y-glutamyl amino acids formed on or near 
the cell membrane by the action of membrane-bound 
y-glutamyl transpeptidase [27]. Although y-glutamyl 
transpeptidase is expressed in the apical membrane 
of human pancreatic duct cells [28], this cycle plays 
no role in amino acid transport across the basolat- 
eral membrane of the exocrine pancreatic epithelium 
[29]. The specific inhibition of cystine transport in 
AR42J acinar and ~TC3 islet cells (Fig. 1B and 
Fig. 2B) by glutamate and homocysteate suggests 
further that system x c, rather than the less selective 
amino transport systems b°'+ and B °,+ [30,31], medi- 
ates entry of cystine in these cells. 
Islet cells are known to have low levels of antiox- 
idant enzyme gene expression [32], which may ex- 
plain their sensitivity to the cytotoxic actions of nitric 
oxide generated by inducible nitric oxide synthase 
during acute and chronic inflammation of the pan- 
creas [33-35]. As GSH contributes ignificantly to 
cellular defences against oxidative stress, including 
nitric oxide-induced cytotoxicity [36], our findings 
in [3TC3 islet cells suggest that the sensitivity of pan- 
creatic [3-cells to oxidative stress in vivo may be at- 
tributable to their low expression of system x S- com- 
pared to AR42J acinar cells. 
Glutathione and cysteine contents are decreased 
markedly in cultured mouse lymphoma L1210 cells, 
which are deficient in cystine transport activity [23]. 
Treatment of [3TC3 islet cells with 2-mercaptoethanol 
significantly elevated intracellular GSH levels, con- 
firming earlier reports in L1210 lymphoma nd islet 
cell lines [8,23]. The reaction of 2-mercaptoethanol 
with cystine produces a mixed disulphide and cys- 
teine which are taken up into cells. The mixed disul- 
phide is then reduced to cysteine and 2-mercapto- 
ethanol and efflux of 2-mercaptoethanol and its rapid 
reaction again with cystine in the culture medium 
enables cells to utilize cystine more efficiently [23]. 
Specific cells in the central nervous system are also 
deficient in cystine transport activity [26]. Glial cells 
express a high activity of system x c whilst neurones 
are only able to maintain intracellular GSH levels by 
taking up cysteine released from glial cells. As the 
GSH content in islets and islet cell lines [8] (see Ta- 
bles 2 and 3) is extremely low in the absence of ex- 
tracellular thiols, it is possible that pancreatic ~l-cells 
in vivo maintain their GSH content by taking up 
cysteine released from surrounding pancreatic acinar 
and ductal epithelial cells. 
On the basis of the results presented in Figs. 3-6, 
one would initially conclude that a decrease in pan- 
creatic GSH is associated with an induction of sys- 
tem x c transport activity. However, as shown in Ta- 
ble 3, depletion of GSH following inhibition of GSH 
synthesis with buthionine sulphoximine (BSO) does 
not seem to be a sufficient signal to induce system xc 
in AR42J acinar or [3TC3 islet cells. Treatment of 
these pancreatic ell lines with BSO decreased intra- 
cellular GSH levels without altering cystine transport 
rates significantly. Our findings with BSO are consis- 
tent with similar studies in human umbilical vein 
endothelial cells [37] but contrast with the reported 
stimulation of cystine and glutamate transport in 
bovine pulmonary artery endothelial cells [11]. Dur- 
ing inhibition of GSH synthesis by BSO, cysteine 
accumulates within cells. In contrast, prolonged ex- 
posure to elevated extracellular concentrations of 
glutamate or homocysteate inhibits cystine transport, 
resulting in low intracellular concentrations of cys- 
teine and GSH. Under these conditions, induction of 
system x c transport activity appears to be mediated 
by the total depletion of non-protein SH groups 
rather than changes in GSH alone. 
In caerulein-induced xperimental pancreatitis, to- 
tal GSH levels in pancreatic homogenates decrease 
substantially within 2-4 h after caerulein treatment 
and are restored to normal within 24 h of discontin- 
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uing caerulein treatment [3,4,7]. Reactive oxygen rad- 
icals generated in acute pancreatitis [2,38-40] are 
probably responsible for the initial depletion of pan- 
creatic GSH. As system x c is induced by reactive 
oxygen radicals and sulfhydryl reactive agents 
[9,11,13], one could speculate that induction of this 
transporter in pancreatitis would increase the supply 
of cystine required to restore depleted pancreatic 
GSH levels. Such an adaptive increase in system x c 
transport activity may play an important role in at- 
tenuating oxidative stress induced by acute pancrea- 
titis and diabetes in vivo. 
Although the signalling mechanisms underlying in- 
duction of  the gene encoding the transporter for sys- 
tem x~- remain to be elucidated, we hypothesize that 
alterations in the intracellular redox state of pancre- 
atic cells activates a transcription factor(s) associated 
with electrophile-responsive/antioxidant-responsive 
elements in stress response genes [21,22,24]. Intracel- 
lular GSH levels in these pancreatic ell types is de- 
pendent on the activity of system Xc, and induction 
of cystine transport by oxidative stress and electro- 
philic agents ensures enhanced supply of cyst(e)ine 
for GSH synthesis. Further studies at a molecular 
level are necessary to identify which transcription 
factor(s) are involved in the induction of system x~- 
transporter in response to inflammation in pancreatic 
disease. 
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